PROCEPT BioRobotics Corporation (PRCT)Healthcare | Medical Devices | San Jose, United States | NasdaqGM
17.51 USD
-1.59
(-8.325%) ⇩
(Oct. 14, 2026, 4 p.m.
EDT)
After hours: 17.51 |
Hot Take ↕ | Oct. 10, 2026, 8:34 a.m. EDT
The investment case for this medical robotics company is currently paralyzed by a severe fundamental crisis. Despite showing a 19% revenue growth rate, the company is burning cash aggressively, with operating cash flow and free cash flow both deeply negative. This operational bleed has crushed shareholder value, driving the stock down nearly 55% year-over-year and erasing almost half of its gains from the previous year. The balance sheet is fragile, with negative returns on equity and assets, and the market has rightly priced this into a negative forward P/E. Compounding the distress is a toxic legal environment, with repeated class-action lawsuits targeting investors who suffered losses, which creates significant overhang and uncertainty. While the long-term technology may be sound, the current execution and financial reality make this a dangerous hold. On the short end, the technical picture is grim, trading well below its 50-day and 200-day moving averages with no immediate catalyst to reverse the trend. Options activity confirms this pessimism, with traders stacking put options to hedge against further drops rather than betting on a rally. Until the bleeding stops and profitability returns, this remains a speculative trap. |
| Model | MAE |
|---|---|
| AutoETS ✓ | 0.110661 |
| MSTL | 0.114859 |
| AutoTheta | 0.144307 |
| AutoARIMA | 0.176580 |
Forecast horizon: 45 days | Selected: AutoETS
| Forecast Reliability | |
|---|---|
| Score | 42% |
| H-stat | 0.28 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.198 |
| Excess Kurtosis | -1.08 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 22.789 |
| Revenue per Share | 5.987 |
| Market Cap | 1,002,861,824 |
| Forward P/E | -14.94 |
| Beta | 0.92 |
| Profit Margins | -32.53% |
| Website | https://www.procept-biorobotics.com |
As of Oct. 10, 2026, 8:34 a.m. EDT: Speculators are heavily positioning for downside protection, evidenced by massive open interest in out-of-the-money puts (strikes at $20 and $40 for April 2027) compared to negligible call volume. While there is some speculative call activity at distant strikes ($32.50, $40.00), the overwhelming capital allocation is defensive, suggesting a fear of further significant declines rather than a bullish breakout.
| Attribute | Value |
|---|---|
| 52 Week Change | -0.48133886 |
| Address1 | 150 Baytech Drive |
| All Time High | 103.81 |
| All Time Low | 15.38 |
| Ask | 22.04 |
| Ask Size | 2 |
| Audit Risk | 6 |
| Average Analyst Rating | 2.5 - Hold |
| Average Daily Volume10 Day | 1,379,480 |
| Average Daily Volume3 Month | 1,452,587 |
| Average Volume | 1,452,587 |
| Average Volume10Days | 1,379,480 |
| Beta | 0.918 |
| Bid | 13.9 |
| Bid Size | 2 |
| Board Risk | 5 |
| Book Value | 5.94 |
| City | San Jose |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Compensation Risk | 10 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 17.51 |
| Current Ratio | 6.547 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,790,726,400 |
| Day High | 19.02 |
| Day Low | 17.49 |
| Debt To Equity | 22.789 |
| Display Name | PROCEPT BioRobotics |
| Dividend Yield | 0.0 |
| Earnings Call Timestamp End | 1,793,827,800 |
| Earnings Call Timestamp Start | 1,793,827,800 |
| Earnings Timestamp | 1,793,822,400 |
| Earnings Timestamp End | 1,793,822,400 |
| Earnings Timestamp Start | 1,793,822,400 |
| Ebitda | -110,078,000 |
| Ebitda Margins | -0.32631 |
| Enterprise To Ebitda | -7.744 |
| Enterprise To Revenue | 2.527 |
| Enterprise Value | 852,447,744 |
| Eps Current Year | -1.68205 |
| Eps Forward | -1.17184 |
| Eps Trailing Twelve Months | -1.78 |
| Esg Populated | 0 |
| Exchange | NGM |
| Exchange Data Delayed By | 15 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 19.8782 |
| Fifty Day Average Change | -2.3682003 |
| Fifty Day Average Change Percent | -0.11913554 |
| Fifty Two Week Change Percent | -48.133884 |
| Fifty Two Week High | 38.11 |
| Fifty Two Week High Change | -20.6 |
| Fifty Two Week High Change Percent | -0.5405405 |
| Fifty Two Week Low | 16.665 |
| Fifty Two Week Low Change | 0.8449993 |
| Fifty Two Week Low Change Percent | 0.050705027 |
| Fifty Two Week Range | 16.665 - 38.11 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,631,712,600,000 |
| Float Shares | 55,809,172 |
| Forward Eps | -1.17184 |
| Forward P E | -14.942314 |
| Free Cashflow | -48,970,248 |
| Full Exchange Name | NasdaqGM |
| Full Time Employees | 888 |
| Fullday Change | -1.5900002 |
| Fullday Change Percent | -8.324608 |
| Fullday Price | 17.51 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Governance Epoch Date | 1,790,812,800 |
| Gross Margins | 0.63362 |
| Gross Profits | 213,746,000 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.03489 |
| Held Percent Institutions | 0.97739 |
| Implied Shares Outstanding | 57,273,659 |
| Industry | Medical Devices |
| Industry Disp | Medical Devices |
| Industry Key | medical-devices |
| Ipo Expected Date | 2,021-09-15 |
| Is Earnings Date Estimate | 0 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology in the United States and internationally. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery focusing on treating benign prostatic hyperplasia. The company also provides HYDROS Robotic System, which provides Aquablation therapy image-guided robotic therapy to treat males suffering from lower urinary tract symptoms due to benign prostatic hyperplasia. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California. |
| Long Name | PROCEPT BioRobotics Corporation |
| Market | us_market |
| Market Cap | 1,002,861,824 |
| Market State | PREPRE |
| Max Age | 86,400 |
| Message Board Id | finmb_248398889 |
| Most Recent Quarter | 1,782,777,600 |
| Net Income To Common | -109,755,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 1,036,939,596 |
| Number Of Analyst Opinions | 12 |
| Open | 19.0 |
| Operating Cashflow | -74,340,000 |
| Operating Margins | -0.32054 |
| Overall Risk | 9 |
| Payout Ratio | 0.0 |
| Phone | 650 232 7200 |
| Post Market Change | 0.0 |
| Post Market Change Percent | 0.0 |
| Post Market Price | 17.51 |
| Post Market Time | 1,792,008,048 |
| Previous Close | 19.1 |
| Price Eps Current Year | -10.409917 |
| Price Hint | 2 |
| Price To Book | 2.9478114 |
| Price To Sales Trailing12 Months | 2.9728432 |
| Profit Margins | -0.32535 |
| Quick Ratio | 5.226 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | hold |
| Recommendation Mean | 2.53333 |
| Region | US |
| Regular Market Change | -1.59 |
| Regular Market Change Percent | -8.32461 |
| Regular Market Day High | 19.02 |
| Regular Market Day Low | 17.49 |
| Regular Market Day Range | 17.49 - 19.02 |
| Regular Market Open | 19.0 |
| Regular Market Previous Close | 19.1 |
| Regular Market Price | 17.51 |
| Regular Market Time | 1,792,008,000 |
| Regular Market Volume | 1,725,638 |
| Return On Assets | -0.14753 |
| Return On Equity | -0.30241 |
| Revenue Growth | 0.193 |
| Revenue Per Share | 5.987 |
| Sand P52 Week Change | 0.1570785 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Share Holder Rights Risk | 8 |
| Shares Outstanding | 57,273,659 |
| Shares Percent Shares Out | 0.1297 |
| Shares Short | 7,427,237 |
| Shares Short Previous Month Date | 1,788,134,400 |
| Shares Short Prior Month | 7,248,594 |
| Short Name | PROCEPT BioRobotics Corporation |
| Short Percent Of Float | 0.13350001 |
| Short Ratio | 5.41 |
| Source Interval | 15 |
| State | CA |
| Symbol | PRCT |
| Target High Price | 30.0 |
| Target Low Price | 16.0 |
| Target Mean Price | 22.33333 |
| Target Median Price | 20.5 |
| Total Cash | 227,914,000 |
| Total Cash Per Share | 3.979 |
| Total Debt | 77,500,000 |
| Total Revenue | 337,340,992 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -1.78 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 24.11125 |
| Two Hundred Day Average Change | -6.6012497 |
| Two Hundred Day Average Change Percent | -0.27378297 |
| Type Disp | Equity |
| Volume | 1,725,638 |
| Website | https://www.procept-biorobotics.com |
| Zip | 95,134 |